Given the increasing prevalence and mortality rates, targeted strategies are needed to reduce this growing health burden in ...
Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback